. Author manuscript; available in PMC: 2019 Oct 1.

Published in final edited form as: Clin Pharmacol Ther. 2018 Jan 30;104(4):664–674. doi: 10.1002/cpt.1006

Table 2.

Pharmacogenomic testing

Institution	Gene(s) tested	Platform	CYP2C19 Alleles reported
University of Alabama at Birmingham	CYP2C19 only	Spartan RX, Spartan Biosciences (Ottawa, ON)	^2, ^3, ^*17
University of Pennsylvania	CYP2C19 only	Spartan RX, Spartan Biosciences (Ottawa, ON)	^2, ^3, ^*17
University of Florida Health, Jacksonville	CYP2C19 only	Spartan RX, Spartan Biosciences (Ottawa, ON)	^2, ^3, ^*17
University of Illinois at Chicago	CYP2C19 only	eSensor XT-8, GenMark Diagnostics (Carlsbad, CA)	^2, ^3, ^4,^5, ^6, ^8,, ^9, ^10, ^*13,^*17
University of Florida Health, Shands Hospital, Gainesville	CYP2C19 only^*	eSensor XT-8, GenMark Diagnostics (Carlsbad, CA)	^2, ^3, ^4,^5, ^6, ^8,^9, ^10, ^*13,^*17
University of Pittsburgh, UPMC Presbyterian Hospital	CYP2C19 only	eSensor XT-8, GenMark Diagnostics (Carlsbad, CA)	^2, ^3, ^4,^5, ^6, ^7,^8, ^9, ^*10,^*17
University of North Carolina at Chapel Hill	CYP2C19 only	Custom Taqman^® assay, ThermoFisher (Waltham, MA)	^2, ^3, ^*17
University of Maryland, Baltimore	CYP2C19 only	Custom Taqman^® assay, ThermoFisher (Waltham, MA)	^2, ^3, ^4,^6, ^8, ^17
Sanford Health	CYP2C19 only	BeadXpress ADME Panel, Illumina (San Diego, CA)	^2, ^3, ^4,^5, ^6, ^8,^*12, ^*17
Indiana University	Panel	Custom Taqman^® assay, ThermoFisher (Waltham, MA)	^2, ^3, ^4,^4B, ^6, ^8,^*10, ^*17
Icahn School of Medicine at Mount Sinai and the Mount Sinai Hospital	Panel	MassARRAY, Agena Biosciences (San Diego, CA)	^2, ^3, ^4,^5, ^6, ^7,^8, ^17
Vanderbilt University	Panel	Custom QuantStudio^® assay, ThermoFisher (Waltham, MA)	^2, ^3, ^4,^5, ^6, ^7,^8, ^17

Initially launched with multi-gene panel based testing, but changed to CYP2C19 testing only after the first year